News May 2016
Enzyre BV, a company developing a point-of-care platform technology for enzymatic reactions, was founded on May 17, 2016. Dr. Waander van Heerde, an experienced blood coagulation physiologist, and Drs. Guido Maertens, a seasoned biotech entrepreneur, are founders of this highly innovative company with the mission to bring personalized diagnostics to the patient. Personalized diagnostics as Enzyre envisions it will open up the way to true personalized medicine and disease management. The focus will lay on the development of a series of tests for blood coagulation initially.